We are live on ! Find out more
CLPT icon

ClearPoint Neuro

69 hedge funds and large institutions have $97.5M invested in ClearPoint Neuro in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $4.34M | Put options by funds: $2.99M

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

4% less capital invested

Capital invested by funds: $102M → $97.5M (-$4.58M)

1.29% less ownership

Funds ownership: 25.82%24.53% (-1.3%)

9% less funds holding

Funds holding: 7669 (-7)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
1.21%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
24
Reduced
19
Closed
17
Calls
$4.34M
Puts
$2.99M
Net Calls
+$1.34M
Net Calls Change
-$286K
Name Holding Trade Value Shares
Change
Change in
Stake
BC
26
Blackcrane Capital
Washington
$512K +$21.8K +1,164 +4%
WMC
27
Westwood Management Corporation
Illinois
$461K
SAM
28
Silvercrest Asset Management
New York
$447K +$28.1K +1,500 +6%
Simplex Trading
29
Simplex Trading
Illinois
$441K -$16.9K -900 -4%
UBS Group
30
UBS Group
Switzerland
$362K +$24.9K +1,330 +7%
Jane Street
31
Jane Street
New York
$300K +$317K +16,887 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$258K +$32K +1,704 +13%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$253K -$34.2K -1,823 -11%
MOS
34
MGO One Seven
Ohio
$250K +$7.5K +400 +3%
AQR Capital Management
35
AQR Capital Management
Connecticut
$242K +$255K +13,614 New
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$233K +$23.4K +1,249 +10%
Morgan Stanley
37
Morgan Stanley
New York
$230K -$350K -18,641 -59%
Invesco
38
Invesco
Georgia
$229K +$242K +12,922 New
CSS
39
Cubist Systematic Strategies
Connecticut
$220K -$114K -6,076 -33%
Deutsche Bank
40
Deutsche Bank
Germany
$211K -$4.95K -264 -2%
Group One Trading
41
Group One Trading
Illinois
$197K -$47.2K -2,515 -18%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$190K -$285K -15,210 -59%
PI
43
PEAK6 Investments
Illinois
$186K +$197K +10,498 New
AIG
44
American International Group
New York
$185K -$2.27K -121 -1%
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$185K +$196K +10,460 New
Brown Advisory
46
Brown Advisory
Maryland
$184K -$91K -4,850 -32%
LPL Financial
47
LPL Financial
California
$183K +$5.63K +300 +3%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$182K -$15.5K -825 -7%
Los Angeles Capital Management
49
Los Angeles Capital Management
California
$181K
Bank of America
50
Bank of America
North Carolina
$166K +$7.52K +401 +4%

CLPT Hedge Fund Activity: Q3 2021 in Review

69 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2021, worth a combined $97.5M — down 4.5% from $102M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CLPT and 11 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 24 added.

The largest buyer was Royce & Associates, adding an estimated $9.82M. The largest seller was Parian Global Management, cutting an estimated $9.85M.

  • 69 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2021, down from 76 in Q2 2021.
  • Funds reported $97.5M of ClearPoint Neuro stock for Q3 2021, down 4.5% quarter-over-quarter.
  • 11 funds opened new ClearPoint Neuro positions in Q3 2021 and 17 closed out, a net change of -6 holders.
  • The largest ClearPoint Neuro buyer in Q3 2021 was Royce & Associates, an estimated $9.82M added.
  • The largest ClearPoint Neuro seller in Q3 2021 was Parian Global Management, an estimated $9.85M sold.

Based on aggregated 13F filings for Q3 2021.